• Citer

Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

par Condorelli, Rosaria;Mosele, F.;Verret, Benjamin;Bachelot, Thomas;Bedard, Philippe L;Cortes, Javier;Hyman, David D.M.;Juric, Dejan;Krop, Ian;Bieche, Ivan;Saura, Cristina;Sotiriou, Christos ;Cardoso, Fatima ;Loibl, Sibylle;Andre, Fabrice;Turner, Nicholas C
Référence Annals of oncology, 30, 3, page (365-373)
Publication Publié, 2019-03-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Auteur:	Condorelli, Rosaria; Mosele, F.; Verret, Benjamin; Bachelot, Thomas; Bedard, Philippe L; Cortes, Javier; Hyman, David D.M.; Juric, Dejan; Krop, Ian; Bieche, Ivan; Saura, Cristina; Sotiriou, Christos; Cardoso, Fatima; Loibl, Sibylle; Andre, Fabrice; Turner, Nicholas C
Informations sur la publication:	Annals of oncology, 30, 3, page (365-373)
Statut de publication:	Publié, 2019-03-01
Sujet CREF:	Cancérologie
	Sciences bio-médicales et agricoles
	Médecine pathologie humaine
Mots-clés:	breast cancer
	genomic alterations
	precision medicine
	target prioritization
	targeted therapies
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1093/annonc/mdz036
	info:pii/5305018
	info:scp/85064114526
	info:pmid/30715161